Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Breast Cancer Res (2011) 13(2):206
In the cell-free GCLC enzymatic assay, BSO inhibited the activity of GCLC with an IC50 of 570 nM [95% confidence interval (CI) 429757 nM
Gut microbiota severely hampers the observed endpoints of NAD-lowering research [PMID: 35396381] Laboratory literature summary: Gut microbiota severely hampers the observed endpoints of NAD-lowering research protocol in leukemia
The goal is to find an optimal balance that maximizes synergistic effects while minimizing potential complexities in the research model
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
